ArticleNature communications2026

CRISPR activation screens identify oncogenic lncRNAs that are susceptible to CDK4/6 inhibitor treatment.

Yifei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.